CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

Access
info:eu-repo/semantics/openAccessDate
2021Author
Karaaslan, ZerrinKurtuncu, Murat
Akcay, Halil Ibrahim
Gunduz, Tuncay
Altunrende, Burcu
Turkoglu, Recai
Eraksoy, Mefkure
Metadata
Show full item recordAbstract
[No Abstract Availale]